EPIDIOLEX® (cannabidiol) Oral Solution for the Treatment of Seizures Associated with Lennox-Gastaut Syndrome, Dravet Syndrome, and Tuberous Sclerosis Complex
Event Type: Webinar
Date: July 19, 2022
Time: 3:00 pm (EST)
Presenters:
Kendra L. Davies, PharmD, RPh
Sponsor by: Jazz Pharmaceuticals
Presentation will include an overview of Syndromes with Refractory Epilepsy (Lennox-Gastaut Syndrome (LGS), Dravet Syndrome (DS) & Tuberous Sclerosis Complex (TSC)), a brief introduction of Cannabinoid Science, a description of EPIDIOLEX Randomized Controlled Trials and EPIDIOLEX Labeling Information
Register Now!
This webinar is complimentary for members and non-members